Aerovate Therapeutics, Inc. Common Stock

AVTE

...

AVTE: Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe.

Show AVTE Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of AVTE by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by AVTE's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on AVTE's company Twitter account

WallStreetBets

Number of mentions of AVTE in WallStreetBets Daily Discussion

AVTE News

Recent insights relating to AVTE

CNBC Recommendations

Recent picks made for AVTE stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AVTE

Corporate Flights

Flights by private jets registered to AVTE